Davenport & Co’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,153
| Closed | -$255K | – | 1028 |
|
|
2022
Q1 | $255K | Sell |
3,153
-100
| -3% | -$8.09K | ﹤0.01% | 906 |
|
|
2021
Q4 | $659K | Sell |
3,253
-1,368
| -30% | -$277K | ﹤0.01% | 666 |
|
|
2021
Q3 | $1.24M | Buy |
4,621
+666
| +17% | +$178K | 0.01% | 493 |
|
|
2021
Q2 | $1.01M | Sell |
3,955
-332
| -8% | -$84.7K | 0.01% | 474 |
|
|
2021
Q1 | $1.29M | Buy |
4,287
+300
| +8% | +$90K | 0.01% | 344 |
|
|
2020
Q4 | $1.02M | Buy |
3,987
+100
| +3% | +$25.5K | 0.01% | 368 |
|
|
2020
Q3 | $967K | Sell |
3,887
-283
| -7% | -$70.4K | 0.01% | 346 |
|
|
2020
Q2 | $1.45M | Hold |
4,170
| – | – | 0.02% | 274 |
|
|
2020
Q1 | $1.12M | Buy |
4,170
+433
| +12% | +$116K | 0.02% | 278 |
|
|
2019
Q4 | $1.21M | Buy |
3,737
+3,165
| +553% | +$1.02M | 0.01% | 313 |
|
|
2019
Q3 | $305K | Hold |
572
| – | – | ﹤0.01% | 556 |
|
|
2019
Q2 | $305K | Buy |
572
+7
| +1% | +$3.73K | ﹤0.01% | 559 |
|
|
2019
Q1 | $285K | Buy |
+565
| New | +$285K | ﹤0.01% | 549 |
|